# Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

> **NCT02687867** · — · COMPLETED · sponsor: **Bayer** · enrollment: 56039 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Dabigatran (Pradaxa)
- **DRUG:** Vitamin K antagonist

## Key facts

- **NCT ID:** NCT02687867
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-12
- **Primary completion:** 2016-03-01
- **Final completion:** 2016-03-01
- **Target enrollment:** 56039 (ACTUAL)
- **Last updated:** 2017-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687867, "Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02687867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*